Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

In the Literature

  • Article

    Time to Benefit of SGLT-2 Inhibitors Among Patients with HF

    April 1, 2024

    Clinical question: What is the time to benefit for patients with heart failure (HF) and prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor? Background: SGLT-2 inhibitors are an effective...

  • Article

    Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum

    April 1, 2024

    Clinical question: Can serum procalcitonin reliably detect bloodstream infections upon hospital admission? Background: Hospitalists frequently manage patients with bacteremia, which is often...

  • Article

    Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

    April 1, 2024

    Clinical question: Does pitavastatin decrease major adverse cardiovascular events (MACEs) in patients infected by the human immunodeficiency virus (HIV) who are on antiretroviral therapy (ART) and...

  • Article

    DAPT Versus Alteplase for Patients With Minor Non-disabling Acute Ischemic Stroke

    April 1, 2024

    Clinical question: Is dual antiplatelet therapy (DAPT) non-inferior to intravenous thrombolysis in patients with minor non-disabling acute ischemic stroke? Background: Intravenous thrombolytics are...

  • Article

    Early Restrictive or Liberal Fluid Management for Sepsis-induced Hypotension

    April 1, 2024

    Clinical question: What’s the effect of restrictive versus liberal fluid resuscitation strategies in sepsis-induced hypotension on 90-day mortality? Background: Intravenous fluid resuscitation is...

  • Article

    Moderate-intensity Statin With Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy in Patients at Very High Risk of ASCVD

    April 1, 2024

    Clinical question: Can you use a moderate-intensity statin with ezetimibe combination therapy for very high-risk (VHR) patients with ASCVD? Background: The ACC/AHA guidelines recommend the use of...

  • Article

    Aspirin or LMWH for Thromboprophylaxis After a Fracture

    April 1, 2024

    Clinical question: Can you use aspirin as a safe alternative to low-molecular-weight heparin (LMWH) for thromboprophylaxis in patients with an extremity fracture? Background: Many guidelines...

  • Article

    Comparison of Standard Dose, High Dose, and Therapeutic Anticoagulation in Hypoxemic COVID-19 Patients

    April 1, 2024

    Clinical question: Does standard-dose prophylactic anticoagulation (SD-PA), high-dose prophylactic anticoagulation (HD-PA), or therapeutic anticoagulation (TA) have a greater benefit in patients with...

  • Article

    Hydrocortisone in Severe CAP

    April 1, 2024

    Clinical question: Do the anti-inflammatory and immunomodulatory effects of glucocorticoids decrease mortality among patients with severe community-acquired pneumonia (CAP)? Background: CAP remains...

  • Article

    DOACs Versus Warfarin Across the Spectrum of Kidney Function

    April 1, 2024

    Clinical question: How safe are direct oral anticoagulants (DOACs) to use in kidney dysfunction? Background: DOACs are increasingly being used in patients with kidney dysfunction. DOACs are cleared,...

Previous1 … 8 9 10 11 12 … 67Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences